SEVENTH AMENDMENTExclusive Patent License Agreement • August 6th, 2009 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Seventh Amendment, effective as of the date set forth above the signatures of the parties below, amends the Amended and Restated Exclusive Patent License Agreement effective November 1, 2002, as subsequently amended by a First Amendment on November 15, 2002, a Letter Agreement on September 12, 2003, a Letter Agreement on October 22, 2003, a Second Amendment on November 19, 2003, a Third Amendment on April 2, 2004, a Fourth Amendment on July 17, 2004, a Fifth Amendment on August 5, 2006, and a Sixth Amendment on January 10, 2007 (“LICENSE AGREEMENT”) between the Massachusetts Institute of Technology (“M.I.T.”), a Massachusetts corporation having its principal office at 77 Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA and Momenta Pharmaceuticals, Inc. (“COMPANY”), a Delaware corporation having its principal office at 675 West Kendall Street, Cambridge, MA 02142, USA.
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 6th, 2009 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Amendment No. 1 (the “Amendment”) to the Asset Purchase Agreement (the “Agreement”) dated April 20, 2007 by and among MOMENTA PHARMACEUTICALS, INC., a Delaware corporation (the “Buyer”), PARIVID, LLC, a Massachusetts limited liability company (the “Seller”) and S. RAGURAM, an individual (“Primary Member”) is entered into as of August 4, 2009.
